ADAM12 is a potential therapeutic target regulated by hypomethylation in triple-negative breast cancer

1. Mendaza, S.
2. Ulazia-Garmendia, A.
3. Monreal-Santesteban, I.
4. Córdoba, A.
5. de Azúa, Y.R.
6. Aguiar, B.
7. Beloqui, R.
8. Armendáriz, P.
9. Arriola, M.
10. Martín-Sánchez, E.
11. Guerrero-Setas, D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/IJMS21030903 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus